Cargando…

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies

Following our recent observation that alterations of the Natural Killer (NK) cell compartment in the presence of BCR-ABL-induced myeloproliferation fail to revert under targeted therapy, we discuss by what mechanisms oncogenic molecular pathways and their pharmacological inhibition may interfere wit...

Descripción completa

Detalles Bibliográficos
Autor principal: Rossig, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382876/
https://www.ncbi.nlm.nih.gov/pubmed/22737614
http://dx.doi.org/10.4161/onci.18401